Ventresca GP - Search Results

1

The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients.

Lötvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca GP, Ward J. Lötvall J, et al. Among authors: ventresca gp. J Allergy Clin Immunol. 2001 Nov;108(5):726-31. doi: 10.1067/mai.2001.119152. J Allergy Clin Immunol. 2001. PMID: 11692096 Clinical Trial.

2

Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man--no evidence of enantioselective lung metabolism.

Ward JK, Dow J, Dallow N, Eynott P, Milleri S, Ventresca GP. Ward JK, et al. Among authors: ventresca gp. Br J Clin Pharmacol. 2000 Jan;49(1):15-22. doi: 10.1046/j.1365-2125.2000.00102.x. Br J Clin Pharmacol. 2000. PMID: 10606833 Free PMC article. Clinical Trial.

3

Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.

Kirby S, Falcoz C, Daniel MJ, Milleri S, Squassante L, Ziviani L, Ventresca GP. Kirby S, et al. Among authors: ventresca gp. Eur J Clin Pharmacol. 2001 Jan-Feb;56(11):781-91. doi: 10.1007/s002280000233. Eur J Clin Pharmacol. 2001. PMID: 11294367 Clinical Trial.

4

Pharmacokinetics of intravenous fluticasone propionate in healthy subjects.

Mackie AE, Ventresca GP, Fuller RW, Bye A. Mackie AE, et al. Among authors: ventresca gp. Br J Clin Pharmacol. 1996 Jun;41(6):539-42. doi: 10.1046/j.1365-2125.1996.36110.x. Br J Clin Pharmacol. 1996. PMID: 8799519 Free PMC article. Clinical Trial.

5

Salmeterol inhaler using a non-chlorinated propellant, HFA134a: systemic pharmacodynamic activity in healthy volunteers.

Kirby SM, Smith J, Ventresca GP. Kirby SM, et al. Among authors: ventresca gp. Thorax. 1995 Jun;50(6):679-81. doi: 10.1136/thx.50.6.679. Thorax. 1995. PMID: 7638815 Free PMC article. Clinical Trial.

6

Clinical pharmacology of HFA134a.

Ventresca GP. Ventresca GP. J Aerosol Med. 1995 Spring;8 Suppl 1:S35-9. doi: 10.1089/jam.1995.8.suppl_1.s-35. J Aerosol Med. 1995. PMID: 10150494 Clinical Trial.

7

Dose-response comparison of broxaterol and salbutamol pressurized aerosols.

Simone P, Borgia M, Torre L, Ventresca GP. Simone P, et al. Among authors: ventresca gp. Eur J Clin Pharmacol. 1990;39(6):565-8. doi: 10.1007/BF00316096. Eur J Clin Pharmacol. 1990. PMID: 1982761 Clinical Trial.

8

Ibopamine kinetics after a single oral dose in patients with congestive heart failure.

Azzollini F, Cattò G, Iacuitti G, Pelosi G, Picca M, Pocchiari F, Pataccini R, Castelnovo P, Longo A, Ventresca GP, et al. Azzollini F, et al. Among authors: ventresca gp. Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):105-12. Int J Clin Pharmacol Ther Toxicol. 1988. PMID: 3410586

9

Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.

Robuschi M, Simone P, Vaghi A, Ventresca GP, Bianco S. Robuschi M, et al. Among authors: ventresca gp. Int J Clin Pharmacol Ther Toxicol. 1987 Feb;25(2):101-4. Int J Clin Pharmacol Ther Toxicol. 1987. PMID: 2881897 Clinical Trial.

10

Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure.

Azzollini F, De Caro L, Longo A, Pelosi G, Rolandi E, Ventresca GP, Lodola E. Azzollini F, et al. Among authors: ventresca gp. Int J Clin Pharmacol Ther Toxicol. 1988 Nov;26(11):544-51. Int J Clin Pharmacol Ther Toxicol. 1988. PMID: 3243658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters